UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

European private equity company Andera Partners today announced that it is co-leading a $159.8 million Series A round of ...

UK-based clinical-stage ophthalmic gene therapy biotech Beacon Therapeutics today announced that it has raised over $75 ...

The launch of USA-based Poplar Therapeutics has been announced, alongside a $50 million Series A financing led by SR One, ...

Swiss biotech TECregen has raised 10 million Swiss francs ($12.6 million) in seed financing to advance its thymus ...

Swiss specialty drugmaker Santhera Pharmaceuticals announces it has signed an exclusive licensing agreement with Nxera Pharma ...

Following rumors over the last couple of days, US pharma major Eli Lilly has confirmed that it plans to acquire Ventyx ...

US biotech InduPro Therapeutics has announced a global strategic collaboration and licensing agreement, and equity investment ...

Indian drugmaker Granules India (BSE: 532482) has announced its US subsidiary has secured tentative approval from the ...

AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...

Danish biotech Genmab (Nasdaq: GMAB) has partnered with artificial intelligence company Anthropic to deploy agentic AI tools ...

Independent French pharma major Servier today announced the creation of Servier Ventures, a fully owned corporate venture ...